NASDAQ: PHXMPhaxiam Therapeutics Sa Stock Ownership - Who owns Phaxiam Therapeutics Sa?
Insider buying vs selling
Have Phaxiam Therapeutics Sa insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when PHXM insiders and whales buy or sell their stock.
PHXM Shareholders
What type of owners hold Phaxiam Therapeutics Sa stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Personalized Indexing Management LLC | 0.78% | 24,271 | $120.00k | Institution |
| Baader Bank Aktiengesellschaft | 0.77% | 24,000 | $118.66k | Institution |
| Mariner LLC | 0.77% | 23,904 | $118.18k | Institution |
| Stonex Group Inc | 0.56% | 17,304 | $85.55k | Institution |
| Citadel Advisors LLC | 0.54% | 16,606 | $82.10k | Institution |
| Millennium Management LLC | 0.39% | 12,069 | $59.67k | Institution |
| Group One Trading LP | 0.34% | 10,590 | $52.36k | Institution |
| Asset Dedication LLC | 0.13% | 4,000 | $19.78k | Institution |
| Ikarian Capital LLC | 0.10% | 3,019 | $14.93k | Institution |
| Concourse Financial Group Securities Inc | 0.00% | 0 | $0.00 | Institution |
PHXM vs Biotech Stocks
Phaxiam Therapeutics Sa Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.